Delivery Order SPE2DB20D3101-SPE2DB22FH8B0

Award Date 2/11/22
Potential Completion Date 2/14/22
Potential Value $20K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity, a medication used to treat type 2 diabetes. The firm-fixed-price delivery order, valued at $1,390.44, has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, that enables the agency...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity (a medication used to treat type 2 diabetes) to the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a type 2 diabetes medication, with a ceiling value of $4,516.65. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen's parent company, Cencora, Inc. The IDC is valued at up to $999,999,999.00 and runs through...
This federal contract award is for the delivery of Trulicity, a prescription medication used to manage diabetes, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,555.35, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held...
This federal contract award is for the delivery of Trulicity medication in the amount of $1,622.88. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $5,207.16 firm-fixed-price contract is for the supply of Trulicity, a medication used to treat type 2 diabetes. The order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which enables DLA to efficiently procure a comprehensive range of...
This federal contract award is for the delivery of Trulicity, a medication used to manage diabetes, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,103.28, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,177.10 delivery order is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication used to manage diabetes. The award is under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,635.51 firm fixed-price delivery order is for the drug Trulicity, a medication used to manage diabetes. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,484.88 firm fixed-price delivery order covers the supply of the drug Trulicity, a medication used for the treatment of diabetes. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FH8B0
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity, a prescription medication for diabetes management. The $19,940.72 firm fixed-price delivery order falls under a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide. The contract award did not have any set-aside designation, indicating open competition.

Generated 2/27/25, 1:16 PM